Maria Tsilika
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Long-term immune and epigenetic dysregulation following COVID-19.
Journal: Clinical immunology (Orlando, Fla.)
Published: October 07, 2025
Antimicrobial Treatment Options for Multidrug Resistant Gram-Negative Pathogens in Bone and Joint Infections.
Journal: Pathogens (Basel, Switzerland)
Published: January 10, 2025
Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk.
Journal: Frontiers in immunology
Published: August 13, 2022
A Four-Probiotic Regime to Reduce Surgical Site Infections in Multi-Trauma Patients.
Journal: Nutrients
Published: May 31, 2022
ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk.
Journal: Frontiers in immunology
Published: February 10, 2022
Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.
Journal: Nature medicine
Published: October 09, 2021
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.
Journal: Nature medicine
Published: June 22, 2021
A four-probiotic preparation for ventilator-associated pneumonia in multi-trauma patients: results of a randomized clinical trial.
Journal: International journal of antimicrobial agents
Published: November 30, 2020
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.
Journal: Journal of the American Society of Nephrology : JASN
Published: June 15, 2020
A novel optical biosensor for the early diagnosis of sepsis and severe Covid-19: the PROUD study.
Journal: BMC infectious diseases
Published: June 14, 2020
Last Updated: 09/26/2026